Ziegler H K, Sinazadeh M
J Neurol. 1975;208(3):207-220. doi: 10.1007/BF00630634.
540 autopsies of institutionalized epileptics who had been treated with anticonvulsant drugs were evaluated as to type and frequency of pathological changes in the liver and compared with a control series of 270 nonepileptics. A specific liver-toxicity of antiepileptic drugs, or combination of drugs, could not be established. Thus, only in 3 cases, one of which was fatal, was a relationship found between anticonvulsant drug therapy and liver damage. Therefore, there seems to be no reason to discontinue anticonvulsant therapy or to reduce the usual dose for fear of causing liver damage. On the other hand, it was found that tuberculosis may have adverse effects upon the liver of patients undergoing anticonvulsant drug therapy. From 41 cases of active tuberculosis we found 13 with severe liver damage, 3 of which were fatal. 10 patients had, and 3 had not, received antituberculosis chemotherapy.
对540名接受抗惊厥药物治疗的住院癫痫患者的尸体解剖进行了评估,以确定肝脏病理变化的类型和频率,并与270名非癫痫患者的对照系列进行比较。无法确定抗癫痫药物或药物组合的特定肝毒性。因此,仅在3例病例中发现抗惊厥药物治疗与肝损伤之间存在关联,其中1例是致命的。因此,似乎没有理由因担心造成肝损伤而停止抗惊厥治疗或减少常用剂量。另一方面,发现结核病可能对接受抗惊厥药物治疗的患者的肝脏产生不利影响。在41例活动性结核病患者中,我们发现13例有严重肝损伤,其中3例是致命的。10名患者接受了抗结核化疗,3名患者未接受。